According to Madrigal Pharmaceuticals 's latest financial reports the company's total debt is $0.11 B. A companyโs total debt is the sum of all current and non-current debts.
Year | Total debt | Change |
---|---|---|
2023-12-31 | $0.11 B | 134.9% |
2022-12-31 | $49.89 M | 6159.85% |
2021-12-31 | $0.79 M | 1.4% |
2020-12-31 | $0.78 M | 16.27% |
2019-12-31 | $0.67 M | |
2018-12-31 | $N/A | |
2015-12-31 | $48.59 M | 249.45% |
2014-12-31 | $13.9 M | -40.57% |
2013-12-31 | $23.39 M | 88.66% |
2012-12-31 | $12.4 M | -25.5% |
2011-12-31 | $16.64 M | 39.97% |
2010-12-31 | $11.89 M | 477.1% |
2009-12-31 | $2.06 M | -50.72% |
2008-12-31 | $4.18 M | -19.9% |
2007-12-31 | $5.22 M | -5.07% |
2006-12-31 | $5.5 M | -10.92% |
2005-12-31 | $6.17 M | 257.91% |
2004-12-31 | $1.72 M | |
2001-12-31 | $N/A |
Company | Total debt | differencediff. | Country |
---|---|---|---|
OPKO Health
OPK | $0.32 B | 178.65% | ๐บ๐ธ USA |
Onconova Therapeutics ONTX | N/A | N/A | ๐บ๐ธ USA |